Jane Nagel
Novartis (Switzerland)(CH)Pathways Behavioral Services(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Ubiquitin and proteasome pathways, Iron Metabolism and Disorders, Autophagy in Disease and Therapy
Most-Cited Works
- → Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide(2014)1,049 cited
- → Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo(2014)724 cited
- → Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses(2007)438 cited
- → Quantitative Lys-ϵ-Gly-Gly (diGly) Proteomics Coupled with Inducible RNAi Reveals Ubiquitin-mediated Proteolysis of DNA Damage-inducible Transcript 4 (DDIT4) by the E3 Ligase HUWE1(2014)70 cited
- Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide(2014)
- The Structure of DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide(2014)